Finding Respect and Ending Stigma around HIV (FRESH) for HIV (Human Immunodeficiency Virus)

University of Alabama at Birmingham (UAB), Birmingham, AL
HIV (Human Immunodeficiency Virus)Finding Respect and Ending Stigma around HIV (FRESH) - Behavioral
Eligibility
Any Age
All Sexes
What conditions do you have?
Select

Study Summary

This trial has the potential to reduce HIV and intersectional stigma across the Spanish-speaking Caribbean by adapting and testing a patient-provider, clinic-based intersectional stigma-reduction intervention.

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3
N/A

Similar Trials

1
Behavioral Self-Regulation Skills Counseling + Stigma Management
1
Intravitreal topotecan with pars plana vitrectomy
1
High ACE Activity Fresh Frozen Plasma

Study Objectives

3 Primary · 1 Secondary · Reporting Duration: Years 1-2

Year 2
Berger HIV Stigma Sclae
HIV Knowledge Scale (HIV-KQ-19)
Stigma and Discrimination in Health Care Facilities
Years 1-2
HIV Continuum of Care Outcomes

Trial Safety

Phase-Based Safety

1 of 3

Similar Trials

1
Behavioral Self-Regulation Skills Counseling + Stigma Management
2
Intravitreal topotecan with pars plana vitrectomy
2
High ACE Activity Fresh Frozen Plasma

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

3 Treatment Groups

Adaptation
1 of 3
First Receipt
1 of 3
Second Receipt
1 of 3

Active Control

Experimental Treatment

92 Total Participants · 3 Treatment Groups

Primary Treatment: Finding Respect and Ending Stigma around HIV (FRESH) · No Placebo Group · N/A

First Receipt
Behavioral
Experimental Group · 1 Intervention: Finding Respect and Ending Stigma around HIV (FRESH) · Intervention Types: Behavioral
Second Receipt
Behavioral
Experimental Group · 1 Intervention: Finding Respect and Ending Stigma around HIV (FRESH) · Intervention Types: Behavioral
AdaptationNoIntervention Group · 1 Intervention: Adaptation · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: years 1-2

Who is running the clinical trial?

Henna BudhwaniLead Sponsor
Florida State UniversityLead Sponsor
173 Previous Clinical Trials
28,650 Total Patients Enrolled

Eligibility Criteria

Age Any Age · All Participants · 10 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You must be at least 18 years old.
You work at one of the three locations where the study is being conducted.
You are able to read and understand Spanish text.
You identify yourself as a sexual and gender minority (SGM).
You have close contact with someone who has HIV.
You speak Spanish.
You understand the study and agree to participate.
You must be at least 16 years old.
You have HIV.
You must receive treatment at one of the three locations where the study is taking place.
References

Frequently Asked Questions

How many individuals have volunteered to participate in this experiment?

"Affirmative. Information on clinicaltrials.gov reveals that this investigation, which was posted in late November of 2020, is presently recruiting subjects. In total there are 3 participants sought from a solitary medical centre." - Anonymous Online Contributor

Unverified Answer

Are there any available slots left in this trial for participants?

"This clinical trial, which was first advertised to the public on November 28th 2020, is still actively recruiting patients. The most recent update of the study's information occurred on August 18th 2022." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top